20 YEAR CHANGES IN FITNESS & CARDIOVASCULAR DISEASE RISK

20年健身变化

基本信息

  • 批准号:
    7174273
  • 负责人:
  • 金额:
    $ 119.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-02-15 至 2008-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Although an age-related decline in aerobic capacity is well documented, the impact of physical activity, body fat, and genetic variation on the rate of change is not well understood. In addition, little is known about how rate of change in aerobic capacity during early and middle adulthood affects the development of cardiovascular disease risk factors or the incidence of subclinical and clinical cardiovascular disease (CVD) related end-points. We propose to address these issues by conducting an ancillary study in conjunction with the Year 20 CARDIA (Coronary Artery Risk Development in Young Adults) examination, which is scheduled to take place beginning in June, 2005. We anticipate that approximately 3,650 (75%) of the surviving members of the initial cohort of African American and white men and women will return for the Year 20 exam, at which point they will be 38-50 years old. The overall goal of the proposed ancillary study is to understand the complex, longitudinal relations between physical fitness, physical activity, body mass and composition and fat distribution, and genetic factors and their independent or interactive effects on the development of obesity, the metabolic syndrome, and sub-clinical CVD. To accomplish this goal, we propose to measure, on all Year 20 CARDIA participants: 1. Aerobic capacity, by means of a symptom-limited graded exercise treadmill test, using the same protocol as that used in CARDIA at the Year 0 and Year 7 exams; 2. Body composition and fat distribution, using a whole body dual energy x-ray absorptiometery (DEXA) scan; 3. Physical activity, using 7 days of accelerometer recordings; and 4. DNA sequence variants in selected candidate genes associated with cardiorespiratory fitness, components of the metabolic syndrome, and response to regular exercise, using stored DNA. Data from this ancillary study will be combined with core CARDIA examination data to address the following aims: a. Examination of the contribution of body mass and composition, fat distribution, objectively measured physical activity and specific genetic polymorphisms to the variance in Year 20 aerobic capacity and in age-related decline in aerobic capacity over a 20-year time period from young adulthood to mid-life, stratifying by race and gender. b. Longitudinal examination of the effect of aerobic capacity on changes in cardiovascular disease risk factors and on the incidence of CVD-related endpoints (e.g. hypertension, metabolic syndrome, subclinical disease [e.g. coronary artery calcium]). Data from this study should provide information that will help us more deeply understand the interrelationships of cardiorespiratory fitness, body composition, and CVD-related risk factors and endpoints, and may provide the basis for more extensive evidence-based recommendations on the role of fitness in cardiovascular health.
描述(由申请人提供):尽管与年龄相关的有氧能力下降有很好的文献记载,但体育活动、体脂和遗传变异对变化率的影响尚不清楚。此外,关于成年早期和中期有氧能力变化率如何影响心血管疾病危险因素的发展或亚临床和临床心血管疾病(CVD)相关终点的发生率,我们知之甚少。为了解决这些问题,我们建议在2005年6月开始进行一项辅助研究,同时进行20岁的CARDIA(年轻人冠状动脉风险发展)检查。我们预计,大约有3650名(75%)的非裔美国人和白人男性和女性的幸存成员将返回20年级考试,届时他们将在38-50岁之间。这项拟议的辅助研究的总体目标是了解身体健康、身体活动、体重和组成、脂肪分布、遗传因素之间复杂的纵向关系,以及它们对肥胖、代谢综合征和亚临床心血管疾病发展的独立或相互作用。为了实现这一目标,我们建议对所有20年级的CARDIA参与者进行测量:

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stephen Sidney其他文献

Stephen Sidney的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stephen Sidney', 18)}}的其他基金

Lifecourse CVD Risk and Midlife Cognitive Trajectories and Brain Aging: Implications for Alzheimer's and Dementia Prevention
生命全程心血管疾病风险、中年认知轨迹和大脑衰老:对阿尔茨海默病和痴呆症预防的影响
  • 批准号:
    10171753
  • 财政年份:
    2019
  • 资助金额:
    $ 119.46万
  • 项目类别:
Determinants of Midlife & Longitudinal Change in Cognitive Function: CARDIA Study
中年的决定因素
  • 批准号:
    9171322
  • 财政年份:
    2014
  • 资助金额:
    $ 119.46万
  • 项目类别:
Determinants of Midlife & Longitudinal Change in Cognitive Function: CARDIA Study
中年的决定因素
  • 批准号:
    8963476
  • 财政年份:
    2014
  • 资助金额:
    $ 119.46万
  • 项目类别:
Development of a Cardiovascular Surveillance System in the CVRN
CVRN 心血管监测系统的开发
  • 批准号:
    7941918
  • 财政年份:
    2009
  • 资助金额:
    $ 119.46万
  • 项目类别:
Development of a Cardiovascular Surveillance System in the CVRN
CVRN 心血管监测系统的开发
  • 批准号:
    7853075
  • 财政年份:
    2009
  • 资助金额:
    $ 119.46万
  • 项目类别:
20 YEAR CHANGES IN FITNESS & CARDIOVASCULAR DISEASE RISK
20年健身变化
  • 批准号:
    7454626
  • 财政年份:
    2005
  • 资助金额:
    $ 119.46万
  • 项目类别:
20 YEAR CHANGES IN FITNESS & CARDIOVASCULAR DISEASE RISK
20年健身变化
  • 批准号:
    6851342
  • 财政年份:
    2005
  • 资助金额:
    $ 119.46万
  • 项目类别:
20 YEAR CHANGES IN FITNESS & CARDIOVASCULAR DISEASE RISK
20年健身变化
  • 批准号:
    7017724
  • 财政年份:
    2005
  • 资助金额:
    $ 119.46万
  • 项目类别:
20 YEAR CHANGES IN FITNESS & CARDIOVASCULAR DISEASE RISK
20年健身变化
  • 批准号:
    7340736
  • 财政年份:
    2005
  • 资助金额:
    $ 119.46万
  • 项目类别:
ORAL CONTRACEPTIVES AND THROMBOEMBOLIC DISEASE
口服避孕药和血栓栓塞性疾病
  • 批准号:
    6056376
  • 财政年份:
    1997
  • 资助金额:
    $ 119.46万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 119.46万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 119.46万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 119.46万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 119.46万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 119.46万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 119.46万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 119.46万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 119.46万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 119.46万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 119.46万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了